- Home
- HMST vs ZURA Comparison
HMST vs ZURA Comparison
Compare HMST & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- ZURA
- Stock Information
- Founded
- HMST 1921
- ZURA 2022
- Country
- HMST United States
- ZURA United States
- Employees
- HMST N/A
- ZURA N/A
- Industry
- HMST Major Banks
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HMST Finance
- ZURA Health Care
- Exchange
- HMST Nasdaq
- ZURA Nasdaq
- Market Cap
- HMST 287.6M
- ZURA 292.1M
- IPO Year
- HMST 2012
- ZURA N/A
- Fundamental
- Price
- HMST $10.82
- ZURA $2.62
- Analyst Decision
- HMST Buy
- ZURA Buy
- Analyst Count
- HMST 2
- ZURA 6
- Target Price
- HMST $14.75
- ZURA $15.80
- AVG Volume (30 Days)
- HMST 153.6K
- ZURA 611.9K
- Earning Date
- HMST 01-27-2025
- ZURA 11-07-2024
- Dividend Yield
- HMST N/A
- ZURA N/A
- EPS Growth
- HMST N/A
- ZURA N/A
- EPS
- HMST N/A
- ZURA N/A
- Revenue
- HMST $169,710,000.00
- ZURA N/A
- Revenue This Year
- HMST N/A
- ZURA N/A
- Revenue Next Year
- HMST $12.08
- ZURA N/A
- P/E Ratio
- HMST N/A
- ZURA N/A
- Revenue Growth
- HMST N/A
- ZURA N/A
- 52 Week Low
- HMST $8.09
- ZURA $2.00
- 52 Week High
- HMST $16.10
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- HMST 37.17
- ZURA 39.80
- Support Level
- HMST $10.60
- ZURA $2.16
- Resistance Level
- HMST $11.95
- ZURA $2.50
- Average True Range (ATR)
- HMST 0.46
- ZURA 0.26
- MACD
- HMST -0.05
- ZURA 0.04
- Stochastic Oscillator
- HMST 10.81
- ZURA 33.33
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.